These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Antibacterial drug discovery: is small pharma the solution? Boggs AF; Miller GH Clin Microbiol Infect; 2004 Nov; 10 Suppl 4():32-6. PubMed ID: 15522038 [TBL] [Abstract][Full Text] [Related]
43. Being a modern pharmaceutical company: new paradigms for the pharmaceutical industry. Hassan F Clin Pharmacol Ther; 2001 May; 69(5):281-5. PubMed ID: 11371995 [No Abstract] [Full Text] [Related]
44. Streamlining drug discovery: finding the right drug against the right target to treat the right disease. Ng JH; Ilag LL Drug Discov Today; 2004 Jan; 9(2):59-60. PubMed ID: 15025066 [No Abstract] [Full Text] [Related]
45. The role of medicinal chemists in drug discovery. Greenlee WJ; Desai MC Curr Opin Drug Discov Devel; 2005 Jul; 8(4):419-20. PubMed ID: 16022177 [No Abstract] [Full Text] [Related]
46. Advancing in the face of conventional wisdom. Lanzara R Drug Discov Today; 2004 Feb; 9(3):110-1. PubMed ID: 14960386 [No Abstract] [Full Text] [Related]
47. Growing pains in AIDS drug development. Herrera S Nat Biotechnol; 2004 Oct; 22(10):1194. PubMed ID: 15470440 [No Abstract] [Full Text] [Related]
48. What's next for an immuno-oncology powerhouse? Mullard A Nat Rev Drug Discov; 2021 Sep; 20(9):660-661. PubMed ID: 34389830 [No Abstract] [Full Text] [Related]
53. High throughput screening: early successes indicate a promising future. Fox S; Wang H; Sopchak L; Khoury R J Biomol Screen; 2001 Jun; 6(3):137-40. PubMed ID: 11689109 [No Abstract] [Full Text] [Related]
54. Steve Carney talks to Mark Ashton and Mark Whittaker about Evotec and their approach to fragment-based drug discovery. Ashton M; Whittaker M Drug Discov Today; 2007 Oct; 12(19-20):789-93. PubMed ID: 18019952 [No Abstract] [Full Text] [Related]
55. [Chemical drug development]. Castro B Ann Pharm Fr; 2002 May; 60(3):147-9. PubMed ID: 12050592 [No Abstract] [Full Text] [Related]
56. In biomarkers we trust? Baker M Nat Biotechnol; 2005 Mar; 23(3):297-304. PubMed ID: 15765081 [No Abstract] [Full Text] [Related]
57. Rho Chi lecture. Pharmaceutical sciences in the next millennium. Triggle DJ Ann Pharmacother; 1999 Feb; 33(2):241-6. PubMed ID: 10084422 [TBL] [Abstract][Full Text] [Related]
58. The abandonment of antibacterials: why and wherefore? Shlaes DM Curr Opin Pharmacol; 2003 Oct; 3(5):470-3. PubMed ID: 14559090 [TBL] [Abstract][Full Text] [Related]
59. At the flick of a switch: epigenetic drugs. Pray L Chem Biol; 2008 Jul; 15(7):640-1. PubMed ID: 18634998 [No Abstract] [Full Text] [Related]
60. Biotechnology discovery productivity: a note of caution. Cavalla D Drug Discov Today; 2003 Nov; 8(21):973-4. PubMed ID: 14643158 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]